With the continuous growth of the demand for medical services in the society, the rapid development of medical devices and the support of the national city policy have also benefited. In recent years, the field of medical devices such as pain management and nasal care has also flourished. On December 13, Jiangsu Aipeng Medical Technology Co., Ltd. (hereinafter referred to as “Aipeng Medical â€) was listed on the Shenzhen Stock Exchange. The opening price was closed at 22.75 yuan per share, an increase of 43.99%. Company profile and performance data It is understood that Aipeng Medical was established on October 30, 2001. The legal representative is Wang Ningyu, which holds 48.20% of the company's total shares. It owns four subsidiaries: Aipu Science, North Qing, Berry Electronics, and Kopenong. Hezhi Medicine Room and Xiaoqing Technology are two Sun companies. Aipang Medical implements functional management and positioning of its subsidiaries, and realizes the coordinated development of various aspects such as brand, application field and talents. The subsidiaries operate relatively independently. Aipang Medical's current shareholding structure The company mainly produces and sells products. Aipeng Medical is a high-tech enterprise mainly engaged in the research, development, production and sales of medical device products for pain management and nasal care. The main products include microcomputer injection pump, disposable injection pump, wireless analgesia management system, pulse oximeter and Medical devices used in the field of nasal care such as medical devices and nasal care sprayers in the field of pain management such as sensors. Among them, the medical devices used in the field of pain management are mainly used for the infusion and monitoring of the medical treatments in postoperative, childbirth, cancer and other clinical treatments to alleviate the pain of patients; the medical instruments used in the field of nasal care are mainly used to relieve nasal dryness, nasal congestion and nose of patients. Discomfort such as bleeding. By the end of September 2018, the company had 61 patents, 3 Class III medical device registration certificates, and Class II medical device registration certificates, and passed ISO9001, ISO13485 and other quality management system certifications. Some products obtained EU CE certification and the United States. FDA certification. From 2015 to 20-18, from January to 2018, Aipang Medical achieved operating income of RMB 153,351,600, RMB 198,031,600, RMB 246,923,300 and RMB 13,166,100, respectively. After deducting non-recurring gains and losses, the net profit attributable to the ordinary shareholders of the parent company was respectively It is 4,031,890 yuan, 4,557,700 yuan, 5,552,790 yuan and 31,540,400 yuan. The medical device industry in which Aipang Medical is located is an emerging industry supported by the national industrial policy, benefiting from the support of national industrial policies and the overall rapid development of the medical device industry. It has maintained a relatively high growth rate. From 2015 to 2017, the compound annual growth rates of operating income and net profit were 26.82% and 42.36%, respectively. From 2015 to 20-18, the total assets of Ai Peng Medical reached RMB 182.28 million, RMB 294.065 million, RMB 33,325,100, and RMB 364,158,800. The total liabilities were RMB 34,881,600, RMB 64,920,100, RMB 5,380,500 and RMB 5,087.44 respectively. Ten thousand yuan. From 2015 to January to June 2018, AiPang Medical's asset-liability ratio was 14.32%, 18.02%, 11.64%, and 10.78%, respectively, and the debt ratio was relatively low. From 2015 to June 2018, Ai Peng Medical's net accounts receivable were RMB 32,401,700, RMB 3,240,870, RMB 3,294,270 and RMB 3,351,560, respectively. The proportion of accounts receivable to operating income was 21.11%. 16.34%, 13.34% and 25.46%, the accounts receivable turnover rate was 5.36, 6.12, 7.56 and 3.96 respectively. Compared with listed companies in the same industry, its accounts receivable accounted for a relatively high proportion of operating income. Fresh Half Shell Mussel Meat,Half Shell Mussel Meat,Frozen Cooked Mussel Meat,Frozen Mussel Shengsi Xiangyuan Aquatic Products Co.,Ltd., , https://www.xiangyuan-aquatic.com
AiPang Medical listed on the 13th, the daily limit of the medical device segment has great potential for development.